Boardroom Drama: A Look At Hostile Bids, Backstabbing And Pharma Coups D'etat

In the midst of a comprehensive cost cutting program rumored to include thousands of job losses, Teva Pharmaceutical Industries' (NYSE: TEVA) chief financial officer Eyal Desheh is about to quit, Israeli press reports.

Mr Desheh would be the latest in a spate of executive departures at the embattled drugmaker, after generics chief executive Siggi Olafsson abruptly downed tools in December, and CEO Erez Vigodman elected not to continue in post earlier this year.

Back to news